tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CASI Pharmaceuticals Reports Q1 2025 Results and Asset Divestiture in China
PremiumCompany AnnouncementsCASI Pharmaceuticals Reports Q1 2025 Results and Asset Divestiture in China
2M ago
Casi Pharmaceuticals reports Q1 EPS (69c) vs. (71c) last year
Premium
The Fly
Casi Pharmaceuticals reports Q1 EPS (69c) vs. (71c) last year
2M ago
CASI Pharmaceuticals Announces CFO Transition
Premium
Company Announcements
CASI Pharmaceuticals Announces CFO Transition
2M ago
CASI Pharmaceuticals Moves to Arbitration in Dispute with Acrotech
PremiumCompany AnnouncementsCASI Pharmaceuticals Moves to Arbitration in Dispute with Acrotech
4M ago
Casi Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright
Premium
The Fly
Casi Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright
4M ago
CASI Pharmaceuticals: Strategic Divestment and CID-103 Potential Drive Buy Rating
Premium
Ratings
CASI Pharmaceuticals: Strategic Divestment and CID-103 Potential Drive Buy Rating
4M ago
Casi Pharmaceuticals reports Fy24 EPS ($2.56) vs. ($2.02) last year
PremiumThe FlyCasi Pharmaceuticals reports Fy24 EPS ($2.56) vs. ($2.02) last year
4M ago
Casi Pharmaceuticals announces anticipated milestones
Premium
The Fly
Casi Pharmaceuticals announces anticipated milestones
4M ago
CASI Pharmaceuticals Secures Interim Relief in Juventas Dispute
Premium
Company Announcements
CASI Pharmaceuticals Secures Interim Relief in Juventas Dispute
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100